About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT01287052

Nitrous Oxide for Acute Migraine Pain in the Emergency Room (ED)

BACKGROUND Migraine headaches account for 8-18% of all headaches seen in pediatric emergency rooms. Standard treatment includes IV pain medications, anti-emetics, and IV fluids. Nitrous oxide has anal...

Lead sponsor: Children's Hospitals and Clinics of Minnesota•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Children's Hospitals and Clinics of Minnesota

Age

8 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•During the study enrollment period, eligible subjects will be English-speaking children and adolescents
•Between the ages of 8 - 18 years (inclusive)
•With history of migraine present for at least one year
•With previous migraine headaches conforming to ICHD-II diagnostic criteria
•Able to give assent according to institutional guidelines, and
•Have parental consent to participate.

Exclusion Criteria

•Any patients will be excluded if he/she
•Has had any neurosurgical interventions
•Has underlying seizure disorders
•Presents with a headache of a different quality than their other migraines
•Has contraindications to nitrous oxide
•Unable to complete the pain assessment
•Does not have a dependable contact number for the follow-up call

Related studies

Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)

NCT06885931 · Mixed Urinary Incontinence, Stress Urinary Incontinence (SUI), and more

Catgut Embedding for Lumbar Spondylosis With Blood Stasis Syndrome

NCT07590050 · Lumbar Spondylosis, Low Back Pain

RECRUITINGPhase 3

Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

NCT06241313 · Migraine

RECRUITINGPhase 3

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

NCT06810505 · Chronic Migraine

RECRUITINGPhase 3

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

NCT07018713 · Chronic Migraine

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 30, 2015Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment30

Start dateJun 2011

Last updatedJul 30, 2015

Condition

Locations shown

Children's Hospitals and Clinics of Minnesota

Minneapolis, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 30, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions